Patents by Inventor Anna V. Stepanenko

Anna V. Stepanenko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250000862
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
    Type: Application
    Filed: September 6, 2024
    Publication date: January 2, 2025
    Inventors: Jayanthy Jayanth, Kevin C. Spence, Gregory A. McClelland, Anna V. Stepanenko, Tzuchi R. Ju, Xi Shao
  • Patent number: 12102637
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
    Type: Grant
    Filed: February 13, 2023
    Date of Patent: October 1, 2024
    Assignees: AbbVie Inc., Neurocrine Biosciences, Inc.
    Inventors: Jayanthy Jayanth, Kevin C. Spence, Gregory A. McClelland, Anna V. Stepanenko, Tzuchi R. Ju, Xi Shao
  • Patent number: 12083227
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: September 10, 2024
    Assignees: AbbVie Inc., Neurocrine Biosciences, Inc.
    Inventors: Yihong Qiu, Yuchuan Gong, Alexander Ruggles, Jared A. Baird, Hui Zu, Gregory A. McClelland, Anna V. Stepanenko
  • Publication number: 20230255968
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
    Type: Application
    Filed: February 13, 2023
    Publication date: August 17, 2023
    Inventors: Jayanthy Jayanth, Kevin C. Spence, Gregory A. McClelland, Anna V. Stepanenko, Kristof Chwalisz, Charlotte D. Owens, James W. Thomas, Jane Castelli-Haley, Keith Gordon, Michael C. Snabes, Ahmed M. Soliman, Geoff Zhang, David Metzger, Yanxia Li, Tzuchi R. Ju, Xi Shao, Oscar Antunez Flores, Rita Jain, Juki Wing-Keung Ng, Janine D. North, Hannah Palac, Paul M. Peloso
  • Publication number: 20190054088
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
    Type: Application
    Filed: August 20, 2018
    Publication date: February 21, 2019
    Applicants: AbbVie Inc., Neurocrine Biosciences, Inc.
    Inventors: Jayanthy Jayanth, Kevin C. Spence, Gregory A. McClelland, Anna V. Stepanenko, Kristof Chwalisz, Charlotte D. Owens, James W. Thomas, Jane Castelli-Haley, Keith Gordon, Michael C. Snabes, Ahmed M. Soliman, Geoff Zhang, David Metzger, Yanxia Li, Tzuchi R. Ju, Xi Shao, Oscar Antunez Flores, Rita Jain, Juki Wing-Keung Ng, Janine D. North, Hannah Palac, Paul M. Peloso, Laura A. Williams